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Background and aims 
The most feared complication of pregnancy is stillbirth. Globally there are 2.6 million 
stillbirths annually with more than 7000 deaths a day. Pregnancies with reduced fetal 
movements have a higher risk of stillbirth and growth restriction. In this thesis, we aimed to 
identify risk factors that are associated with poor neonatal outcome in the group of women 
with reduced fetal movements; to identify preventable stillbirths through an audit process; to 
investigate the intrauterine milieu and the existence of a placental microbiome in full-term 
pregnancies; to investigate if ultrasound and angiogenic markers can be used as predictors of 
the neonatal outcome in pregnancies with reduced fetal movement. 
Methods 
Study I was a retrospective cohort study were all women with pregnancies who attended 
health care for decreased fetal movements at Soder Hospital were included. A composite 
neonatal outcome was constructed and the risk factors for poor neonatal outcome were 
analyzed for this group. 
Study II was a retrospective cohort study conducted as an audit by a multidisciplinary team. 
All stillbirths in Stockholm 2017 were included and the intention was to investigate the 
preventable deaths and standard of care. 
Study III investigated the potential presence of a placental microbiome in full-term 
pregnancies in pregnancies with pre-labor cesarean deliveries and in vaginal deliveries. 
Study IV was a pilot study in which it was investigated if the cerebroplacental ratio, the flow 
in the uterine artery and angiogenic factors could be used as predictors of poor neonatal 
outcome. 
Results 
There was an increased risk of having an Apgar ≤7 at 5’ (RR 1.56, 95% CI 1.25-1.96), pH ≤ 
7.10 (RR 1.34 CI 95% 1.12-1.61) and stillbirth (RR 5.53, CI 95% 2.81-10.85) in the RFM 
group compared with pregnancies without RFM. 
30% of the stillbirth analyzed by the audit were assessed as preventable/possible preventable. 
The non-Swedish speaking women were overrepresented in this group. 
When adding a Doppler examination to standard care for RFM there was a significant 
increase in the obstetrical intervention rate without improvement of the neonatal outcome. 
The predictive model for composite neonatal outcome based on additional Doppler 
angiogenic factors and parity had an AUC of 0.89 (95% CI 0.81–0.97). 
Conclusion 
The highest risk of having a poor neonatal outcome were the small for gestational babies 
(SGA) and the IVF pregnancies in the group of pregnancies with RFM. The audit process of 
stillbirth identified preventable deaths, delays in the health care system and cases with 
substandard care. This leads us to the conclusion that national audits can further improve the 
care for these patients and can possibly help us to reduce the rate of stillbirths. Non-Swedish 
women have a higher risk of stillbirth and those not speaking the language need 
individualized antenatal care. The angiogenic factors can be useful predictors of the neonatal 
outcome, but larger studies are needed. There is no evidence for a placental microbiome in 
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According to WHO: “Stillbirths remain a neglected issue, invisible in policies and programs, 
underfinanced and in urgent need of attention and it is absent from the Millennium 
Development Goals and still missing in the Sustainable Development Goals”. Stillbirths take 
a large emotional and economic toll on individuals, families, medical personnel, and societies 
in its entirety. 
In Sweden, even if the number of stillbirths is low compared to other countries, the stillbirth 
rate has been almost unchanged for the past two decades. The Lancet has recently run a series 
of articles on “stillbirths: ending preventable deaths” and suggested the following actions for 
high income countries as possible ways to reduce stillbirths: improvement in data collection, 
a better classification of the causes of death and improvement in standard care. The same 
studies concluded that the implementation of national perinatal mortality audits can be a way 
of reducing stillbirths’ rate (1-5).  
It has been extensively discussed that pregnancies with reduced fetal movements have an 
increased risk of intrauterine growth restrictions and stillbirths. At the same time, we lack 
evidence that standard care which includes cardiotocography and ultrasound assessment of 
the amniotic fluid can identify the pregnancies with the highest risk of poor neonatal 
outcome. 
The desired outcome for all pregnancies is a healthy mother and a healthy newborn. To 
achieve that it is crucial to be able to distinguish between risk pregnancies that need 










2.1 FETAL MOVEMENTS 
 
2.1.1 Historical perspective 
The first written description of fetal movements is found in the bible, where Rebecca said that 
the “children struggled within her” (Genesis 25:22). The interest and the fascination for what 
happens in the womb have been great during history. Hippocrates (460-370bc) suspected that 
fetal movements start at about 70-90 days after the conception. Leonardo da Vinci sketched 
the famous fetus in the womb. 
A German obstetrician, Johann Ahlfeld, realized in 1869  that the maternal perception of fetal 
movements can be an indicator of fetal well-being (6). The Fells Institute conducted the first 
non-invasive studies of fetal behavior. The fetal heart rate was registered by stethoscope and 
the fetal movements were recorded for 2 hours a week during the whole pregnancy. Sontag 
and Wallance noted that fetal movements differ among fetuses, that maternal emotional stress 
and pre-eclampsia increases fetal movements and that fetuses reacted after vibratory stimulus 
was applied to the maternal abdomen (7).  
The first ultrasound studies of fetal movements were reported by Reinold in 1971. Since then 
other methods of assessing fetal movements and fetal behavior have been tested: intrauterine 
fetal electroencephalogram (Lindsey 1942), fetal magnetoencephalography (Blum 1985), 
magnetic resonance imaging (Prayer 2006), functional magnetic resonance imaging (Gowland 
and Fulford 2004). 
 
 
2.1.2 Why does the fetus move in the uterus? 
During time three different theories on why the fetus moves have emerged and they are 
summarized by Christa Einspieler in her book “Fetal Behavior: a neurodevelopmental 
approach”: 
• The epiphenomenal concept: fetal movements represent an incidental 
epiphenomenon and have no adaptive significance. 
• The preparatory hypothesis: the fetus moves to gain practice and experience 
needed for further development of motor coordination postnatally. 
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• The functional hypothesis: fetal behavior is functional and adaptive during the 
prenatal period. Fetal movements are necessary for normal muscular, skeletal, and 
neurological systems development.  
Nowadays there is increasing evidence that the functional hypothesis is complementary to the 
preparatory theory and that they together best explain the function of embryonic and fetal 
movements. This hypothesis is sustained by studies by Pena and Shokeir that showed that the 
distribution of neurotransmitter receptors on the muscle fibers develop abnormally if the fetal 
movements are silenced pharmacologically or by disease (8). 
 
 
2.1.3 Reduced fetal movements (RFM) 
Previous studies have shown that decreased fetal movements are associated with pregnancy 
complications such as preterm birth, fetal growth restriction and stillbirth (9, 10). 
Both medical professionals and mothers use monitoring of fetal movements as a reassurance 
of fetal well-being during pregnancy. Fetal movements differ during the pregnancy with a 
increase from week 16-20 to week 36, and a slight decline throughout the last month of 
pregnancy (11). The movements vary during normal pregnancies depending on the quantity of 
amniotic fluid, the position of the fetus, maternal medication and the wellbeing of the fetus 
(12).  
When sonographically assessed, the fetal movements are classified into four groups: 
movements of the fetal trunk (hiccup, rotation, breathing), limbs, face, and head. The maternal 
perception of fetal movements can be different compared to the fetal movements visualized 
by the ultrasound. In one study, mothers perceived just 33-88% of the fetal movements seen 
om the ultrasound (13). 
RFM are self-reported by the mothers, with guidance from midwifes and obstetricians. There 
is no gold standard method for counting and reporting RFM.  
The maternal perception of fetal movements  can be affected by stress and anxiety (14), 
medication and smoking (15), localization of placenta (16), maternal position (17), and the 
perception changes throughout the pregnancy. 
It is crucial that the health care providers inform the pregnant woman about the importance 
for her to perceive and assess fetal movements. At the same time, we know that instructing 
women to monitor fetal movements can be associated with increased maternal anxiety. 
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Counting fetal movements can be a difficult task for the mothers, as there is no consensus in 
which method is the most accurate. There are two main methods that are commonly used- 1) 
“fixed time” and 2) “fixed number”. The first one refers to fetal movements which was 
initially counted during 12 hours, but later modified to shorter and repeated periods of 
counting (18). The second method refers to measuring the time in which 10 fetal movements 
have been perceived and has been shown to have a higher compliance rate (19).  However, a 
systematic review reported that the evidence was weak for fetal movement counting as a 
marker for fetal wellbeing (20).  
The current guidelines from Australia, New Zealand and the Royal College of Obstetrics and 
Gynecology emphasize that it is the mother’s perception of reduced fetal movements that is 
important.  
Newer approaches, such as mindfetalness (focusing on the fetus movements 15 minutes a day 
with the women lying on the left side), that are trying to increase the women’s awareness on 
fetal movements, have been evaluated in a cluster-randomized controlled study. And while 
the number of visits to healthcare due to RFM increased in the intervention group, there was 
no reduction in the number of newborns with low Apgar score. Surprisingly there was a 
decreased incidence in cesarean sections and small for gestational age (SGA) babies (21). 
 
2.1.4 Management of reduced fetal movements (RFM) 
The purpose with antenatal care is to identify risk pregnancies and to prevent, if possible, 
adverse maternal and fetal outcomes but to avoid over medicalization. As obstetricians, we try 
to intervene as little as possible, because most of the pregnancies with RFM are normal, but 
among them are also risk pregnancies.  
There is no national consensus on the management of women with RFM, and these women are 
examined or the delivery induced according to local guidelines. The number of pregnant women 
seeking health care for decreased fetal movements has been increasing over the past years (at 
Soder Hospital there are around 2000 visits/year). 
A Cochrane review from 2012 highlighted that there are no randomized control studies about 
the management of pregnancies with RFM and there is not enough evidence to decide which 
management would be the most appropriate (22). Data from Norway suggests that besides CTG 
which is used to assess the fetal well-being, ultrasound plays an important role by detecting 
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abnormalities in 11,6% of the cases with RFM and in most cases with ultrasound findings the 
abnormalities were important for the further management of the pregnancies (23). 
A prospective cohort study on women undergoing elective cesarean section reported that fetuses 
with absence of movements on ultrasound prior to the delivery had lower pH, base excess (BE), 
O2 and a higher CO2 in the umbilical cord than women with active fetuses (24).  
An international survey on 1714 women experiencing stillbirth after 28 weeks of gestation 
reported that 30,5 % of the women felt significantly less fetal movement and 8,5 % significantly 
more movements while 28% felt no change in fetal movements before the stillbirth (25). 
 The Lancet’s stillbirth series identified decreased fetal movements as one, among many others, 
of the key topics in trying to prevent the stillbirths (2). 
 
2.2 STILLBIRTH 
Despite efforts, the incidence of stillbirths is still high globally with an estimated number of 2,6 
million stillbirths occurring every year. Half of them occur during the pregnancy.  
According to statistics from the World Health Organization (2009), on the rate of stillbirth per 
country Sweden is ranking 12th out of the high-income countries, having the highest rate of 
stillbirth among the Scandinavian countries. The incidence of stillbirths in Sweden has shown 
only minor variations during the past 20 years with 400-450 stillbirths/year (26) (Figure 1). 
However, the demography of Swedish population at reproductive age has changed over the 
years with an increase in the percentage of women with high BMI and older nulliparous (27).  
At the same time Sweden has higher rate of women born outside of Europe per capita compared 




In Norway, in an attempt to lower the stillbirths’ rates, the health care system did an 
intervention aiming at standardizing the information given to women with RFM and also to 
standardize the guidelines for management of RFM for obstetricians and midwives. Their 
recommended management of RFM included a non-stress test, an ultrasound to quantify fetal 
movements, measurement of the amniotic fluid volume and the fetal growth and anatomy, and 
the recommendation that women with RFM should be examined within 2 hours if no fetal 
movements were recorded, otherwise within 12 hours. Interestingly the reports of RFM, preterm 
births, fetal growth restriction and transfers to neonatal care did not increase during the 
intervention. The stillbirth rate decreased both in women with RFM and in the overall study 
population from 4.2% to 2.4% and respectively 3.0/1000 vs 2.0/1000 (23).    
The AFFIRM study in the United Kingdom tried a similar approach by trying to increase the 
women’s awareness on reduced fetal movements together with standardized medical 
management of the pregnancy. This was done in a large randomized stepped wedge cluster in 
37 hospitals in UK and more than 400 000 pregnancies were included. The results of the study 
showed a non-significant trend towards fewer stillbirths in the intervention group and a 
statistically significant increase in the rates of cesarean sections and induction of labor (29). 
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Admission CTG has been shown to effectively reduce intrapartum stillbirth, both in low and 
high risk pregnancies. As compared to admission CTG, an in-house hospital care unit had 18-
fold higher risk of stillbirth (0.09% vs 0.995%, OR 18.5 95% CI 3-111) (30). 
 
2.2.1 Classification systems of stillbirths 
One of the problems in reducing the number of stillbirths is the diversity of classification 
systems for cause of death in stillbirths, where more than 35 systems are used (31). Some of the 
classification systems focus on the fetal causes of death (32) while others focus on the maternal 
ones or on both (33, 34). At the same time, the classification systems used in high income 
countries require extensive diagnostics which are not available in a low-income setting. 
The plethora of cause of death classification systems for stillbirth and the use of different 
definitions can make it difficult to compare stillbirths’ rate between different countries.  
 
2.2.2   The importance of audits 
A perinatal audit is “systematic, critical analysis of the quality of perinatal care, including the 
procedures used for diagnosis and treatment, the use of resources and the resultant outcome and 
quality of life for women and their babies” (35). 
The stillbirths audit can be a tool to improve the obstetrical care, to identify preventable 
deaths and to evaluate the quality of antenatal and intrapartum care. Implementation of 
national perinatal mortality audits have been shown to reduce the perinatal mortality and 
identify elements of substandard care (36-38). The impact of an audit is dependent on the 
ability of implementing the recommendations from its conclusions. 
With 75% of the stillbirths occurring in south Asia and sub-Saharan Africa, stillbirth is still a 






2.2.3 What can we do to decrease the rate of stillbirth? 
In high income countries like USA, Nya Zeeland and most of the European countries, 26% of 
all stillbirths occur in term pregnancies (fig.2a and b) where there is the possibility of obstetric 
interventions such as induction of labor (39-42). The solution to this problem is not so simple. 
In 2011, Denmark implemented a more proactive protocol with earlier induction of labor at 
41+3 weeks of gestation compared to the previous routine of 42+0 weeks This change of praxis 
resulted in no differences in neonatal outcomes such as: stillbirths, neonatal death or low Apgar 
scores (43). It is possible that by moving the induction even earlier the results would be better. 
However, the induction rate would increase tremendously and the induction per se is associated 
with potential adverse outcomes (44). 
 
 
 What seems to be important is to be able to identify the risk pregnancies and reserve the 
obstetrical interventions for these pregnancies. 
The SGA babies are overrepresented in the stillbirth group compared to liveborn (45, 46). 
According to the Swedish National Board of Health and  Welfare’s “Stillbirths Report”, in 
Sweden, there are up to 40% of SGA among stillbirths occurring < 37 weeks of gestation and  
11% in the group ≥37 weeks of gestation (47). So, identifying the SGA babies should be a 
priority. However, previous studies, have shown that an ultrasound in the third trimester in low 
risk population has not improved the neonatal outcome (48, 49), but in a selected risk 
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Fig.2b Distribution of neonatal deaths by 








A large South Swedish study performing routine 32-week ultrasound with a predetermined 
surveillance plan showed 4-fold lower risk of stillbirth/newborn death among identified SGA 
cases (50). The  latest Cochrane assessment of late ultrasound showed 20-fold lower risk of 
stillbirth among those scanned (51). 
 
2.3 PLACENTA 
2.3.1 Role and importance 
 
The placenta is a fascinating organ that 
ensures the normal development and growth 
of the fetus. It has multiple functions that 
are important for the normal development of 
the pregnancy such as: gas exchange, 
nutrients and waste transfer, secretion of 
hormones and fetal protection from 




An inadequate functioning placenta can be associated with pregnancy and neonatal 
complications such as: SGA, preeclampsia, and stillbirth. Therefore, pathological examination 
of the placenta is of high importance especially in women with stillbirths. 
Studies have shown that there are morphological changes in the placentas from pregnancies 
with RFM and adverse outcome compared with those without RFM. These placentas were 
smaller, less vascularized, had an abnormal endocrine function (53, 54) or had bigger area 
with signs of infarction, decreased villous vascularity and decreased trophoblast area 
compared with the controls (55).  
 
 




The first sonar studies of fetal movements were reported by Emil Reinold, an obstetrician from 
Vienna in 1971. He found that the first movements appear at a gestation of 9 weeks. Later 
studies with transvaginal probe showed that the earliest body movements occur at 7 weeks and 
2 days (56). 
Since then a lot of other parameters have been added to the ultrasound examination to assess the 
normal development and growth of the fetus. We know that a deterioration in the placental 
function will generate compensatory hemodynamic changes in the fetus with redistribution of 
the blood flow to the brain (“brain-sparing” effect) and other essential organs. This 
redistribution of the blood flow to the brain has been noticed for example in SGA fetuses and is 
associated with both perinatal and long-term neurodevelopmental adverse outcomes  (57, 58). 
To assess these changes, it has been suggested the use of cerebroplacental ratio (CPR) as the 
ratio between the middle cerebral artery pulsatility index (MCA-PI) and the umbilical artery 
pulsatility index (UA-PI). 
The uterine Doppler is a non-invasive way of assessing the maternal compartment of the 
placental function. One of studies regarding the use of uterine artery Doppler in the third 
trimester showed that it is at least as good predictor for the placental insufficiency as the uterine 
artery Doppler in the first trimester  (59). This suggests that the uterine Doppler assessment has 
its place even later in the pregnancy. 
Furthermore, studies from Prior et al showed that independent of fetal size the cerebroplacental 
ratio measured within 72 hours before a delivery could identify the fetuses needing obstetric 
interventions for intrapartum compromise (60). Consistent with these results, the study by 
Moralles-Rosello et al indicated that assessing the CPR- could be a feasible method of detecting 
placental insufficiency even in appropriate for gestation fetuses not reaching their potential (61). 
A large retrospective study with over 9000 pregnancies included showed that a low CPR within 
2 weeks of delivery regardless of the fetal size was associated with intrapartum fetal 
compromise and admission to the neonatal unit (62).  Another retrospective cohort study with 
2812 patients shown that CPR evaluated in the third trimester is an independent predictor of 
stillbirth and perinatal mortality in a mixed risk population (63). 
Triunfo et al reported that the Doppler evaluation of fetal vessels and maternal uterine artery at 
37weeks in a group of low-risk pregnancies improved the prediction of adverse perinatal 
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outcome but not the prediction of small for gestation and fetal growth restriction (64). In 
contrast with these results a prospective cohort study by Rial-Castelo et al with 1030 low-risk 
pregnancies that performed fetal biometry and Doppler ultrasound examinations at 32-34 weeks 
did not find any improved predictive value of CPR and uterine Doppler over standard screening 
practice for impaired fetal growth (65). Notable is that the study site in Barcelona has a routine 
third trimester ultrasound screening.  
A systematic review analyzing the performance of CPR found that 6 of 11 articles reported a 
significant association between low CPR and a lower mean birthweight of the fetus (66).  
An Australian prospective observational study of low risk women at term showed that uterine 
artery PI is higher than 95th centile and the CPR is lower than 10th centile in pregnancies 
delivered with cesarean section for intrapartum fetal compromise and those with composite 
neonatal morbidity (67). 
In a study by Khalil et al a CPR < 5th centile alone was significantly associated with an 
increased risk of perinatal mortality. However, this study did not find CPR MoM (multiples of 
median) to be a significant independent predictor of adverse neonatal outcome (68). These 
findings were in accordance with earlier studies by Nicolaides et al that showed that CPR alone 
at 35-37 weeks of gestation is a poor predictor of adverse perinatal outcome (69). 
A recent meta-analysis by Heidweiller-Schreurs et al, including 128 studies involving 47748 
women explored the prognostic accuracy of CPR in detecting adverse perinatal outcome. They 
summarized that CPR could add value to the uterine artery PI in predicting adverse perinatal 
outcome in singleton pregnancies. However, it is still unclear if this applies for all pregnancies 
(70). 
A study by Bligh et al tried to combine the cerebroplacental ratio and the blood test for PlGF 
(placental growth factor) and assess their screening performance for the detection of cesarean 
section for intrapartum fetal compromise and composite neonatal outcome. The study was 
conducted in a low risk population and women were enrolled from 36 weeks of gestation. There 
was no significant difference between the combined model with CPR and PlGF and its 





2.5 ANGIOGENIC AND ANTIANGIOGENIC FACTORS 
 
2.5.1 Definition 
Angiogenesis, which is the formation of new blood vessels is a multifactorial and very complex 
process. This process can be affected in different situations like cancer, inflammatory diseases, 
hypoxia. 
Angiogenesis allows hematopoietic cells to assure immune surveillance, dispose of waste, 
supply oxygen and nutrients to the cells. The process of angiogenesis is regulated by promoters 
and inhibitors and is very important in many biological processes as for example: reproduction 
and wound repair. 
The most important regulator of angiogenesis is the vascular endothelial growth factor (VEGF) 
family. VEGF-A is essential for both vasculogenesis and angiogenesis. Homozygotes and even 
heterozygotes for the VEGF-A gene in mice die in the embryonic stage. 
The endothelial cells have oxygen sensors for hypoxia-inducible factors(HIF) in order to be able 
to adjust their shape and blood flow when needed. Under hypoxia, HIF factors are activated and 
they generate an upregulation of angiogenic factors such as VEGF. When activated the VEGF 
exerts its biologic effect through interaction with cell surface receptors. VEGF is essential for 
maintaining vascular homeostasis and exerts its effect through two high-affinity receptor 
tyrosine kinases: VEGFR-1 (or sFlt-1) and VEGFR-2 (or KDR/Flk-1). 
Several growths factors as: platelet-derived growth factor (PDGF), transforming growth factor-
β (TGF-β) and angiopoietin are needed for the blood vessels to function properly. Angiopoietin 
1 (Ang 1) stimulates vessel maturation and promotes endothelial cell survival while 
angiopoietin 2 (Ang 2) antagonizes Ang 1 in vivo and acts by enhancing the decay of blood 
vessels. 
Endoglin expression is also upregulated in hypoxic conditions. Endoglin which is a TGF-β 
super family coreceptor cooperates with VEGF to promote angiogenesis. Soluble endoglin 
(sEng) which is a soluble form of a receptor of TGF- β inhibits angiogenesis. Soluble fms-like 
tyrosine kinase 1 (sFlt-1) is another circulating receptor for VEGF and PlGF that suppresses 
angiogenesis by binding these proteins and preventing them from coming in contact with their 
receptors in the endothelial cells in the placenta (72-74). 
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2.5.2 Clinical use 
Vasculogenesis and angiogenesis are very important for the normal evolution of the pregnancy. 
Furthermore, the balance between the angiogenetic and anti-angiogenetic factors is necessary 
for reproduction (75, 76). 
Abnormalities in the maternofetal circulation, intrauterine growth restriction (IUGR), 
preeclampsia and other maternal diseases can affect the oxygen supply both before and during 
the delivery (77). Lately the use of angiogenic factors in obstetrics has increased and they are 
used as predictors in clinical praxis for example in preeclampsia. 
The imbalance of these circulating factors has been noticed in preeclampsia, IUGR and in 
gestational hypertension.  Nanjo et al showed even that the levels of circulating angiogenic and 
anti-angiogenic factors prior to delivery correlate to the severity of hypertensive disorders and 
to IUGR (78). 
Studies in mice shown that HIF increases both in placenta and in the developing brain at 
gestational day 20 in cases of acute antepartum hypoxia (79). High levels of both HIF 1&2 
(Hypoxia-inducible factors) were noticed in human placenta in conditions of chronic hypoxia as 
preeclampsia, IUGR and gestation at high altitude. 
Research in the area has shown that a lower maternal plasma placental growth factor (PlGF), a 
higher soluble endoglin (sEng) and soluble VEGF receptor-1 (sVEGFR-1) were registered in 
pregnancies with subsequently stillbirths compared with normal pregnancies (80).  
Recent data published by Chaiworapongsa et al have found that by testing PlGF, 
PlGF/sVEGFR-1, and PlGF/sEng in the maternal blood at 24-28 weeks of gestation it is 
possible to predict fetal death. According to that study, when the ratio calculated with the 
plasma concentrations of the angiogenic and antiangiogenic factors < 2.5th centile there was a 
29-fold increase of stillbirth with a false positive rate of 3,5% (81). The unexplained stillbirths 









There are hundreds of trillions of microbes existing in symbiosis within the human body and 
they have a profound impact on modulating host function. The largest number of those 
microbes, containing bacteria, fungi, viruses, and protozoans reside in the gastrointestinal tract 
and have been shown to influence normal physiology across all body systems.  During the past 
years, the concept of microbiome-gut-brain axis has emerged and the bidirectional 




The microbiome influences the turnover of neurotransmitters in the CNS, stress reactivity, 
anxiety like behavior, the memory function (through brain derived neurotrophic factor), and 
modulation of the serotoninergic system (83). The gut microbiota’s composition and biomass 
are affected by psychological stressors. The brain has an important role in modulating all the 
intestinal functions and can influence the normal habitat of the gut microbiota. Interestingly, it 
has been shown that the alternation in intestinal function induced by stress facilitates the 
expression of virulent bacteria (84). 
New research shows the influence of gut microbiome on anxiety and depression (85, 86) and 
even on autism (87, 88). Animal studies have shown that the gut microbiome is very important 
for both the development and the maturation of CNS (89, 90). 
Advanced culture-independent methods are revolutionising our insights into the microbial 
presence in the human body. Although the microbiome has been described as the first-line 
defence against colonisation by opportunistic pathogens, (91) it is still unclear how important 
the microbiome is for human health. The term dysbiosis is used to indicate an abnormal or 
unhealthy microbiota composition, yet is still poorly defined. Pregnancy is of particular 
importance since it is the crucial period to establish the microbiome in new-borns, with many 
important physiological changes in the expecting mother. Most microbiome research has 
currently focused on the (lower) gastrointestinal tract. However, there is increasing evidence 
that the microbiome (gut, vagina and other locations) plays an important role during pregnancy, 
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for example in pre-term birth but potentially also maternal complications such as pre-eclampsia, 
gestational diabetes and excessive weight gain (92).  
The often asymptomatic vaginal dysbiosis (also called bacterial vaginosis) has been associated 
with an increased risk of sexually transmitted diseases, reduced fertility and potentially also 
with preterm labor and preterm delivery (93). The maternal microbiome is also seen as a major 
contributor to the microbiome in the infant through the birth process, and there is increasing 
evidence that this process starts even before birth  (92, 94). 
 
2.6.3 Is the womb sterile during pregnancy? 
 
For the last century, it has been assumed that 
the intrauterine environment is sterile. 
The microbial colonization starts early in life 
and it is very important for the physiological 
development of the human fetus. Researchers 
are still debating if the colonization starts 
during and after birth (the sterile womb 
paradigm) or already intrauterine (in utero 
colonization hypothesis). 
The sterile womb paradigm is sustained by 
numerous studies. A study conducted by Harris 
and Brown showed no cultivable bacteria in the 
amniotic fluid of women delivered with C-section, 
when the duration of labor was less than 6 hours (95).  
Further studies showed that in normal healthy pregnancies there are no bacteria in the amniotic 
fluid, placenta or in the meconium (96-100) and that all bacteria identified were from 
contaminations. Other studies using molecular techniques and next generation sequencing have 
suggested that the uterus and placenta have their own microbiome that contributes to the 
colonization of the fetus (101-103). 




Perez-Munoz et al.  reviewed in 2017 the published articles in the field and concluded that the 
assumptions of the sterile womb paradigm are still valid and most of the studies had positive 
finding due to contamination, flawed interpretation of findings and that the bacterial species 
identified by molecular techniques could not be verified by bacterial cultures (104). Since then 
more studies have been showing that there are no signs of a placental microbiome in 
uncomplicated pregnancies at term (100). 
A study by Parnell et al from 2017 challenged this hypothesis by showing that the placenta 
harbors its unique microbiome and moreover that the microbiota has distinct profiles depending 
on the localization within the placenta and that the profiles are not altered by the mode of 
delivery (105). Furthermore, a recent study from Finland by Tapiainen et al has concluded that 
the microbiome of the first-pass meconium was not affected by perinatal factors, but it was 
affected by factors during pregnancy. This suggests that there is a transfer of microbes in utero 
and that the development of the gut microbiome starts in fetal life (106). 
Presence of bacteria in the amniotic fluid or in the placenta have until now been associated with 
complications of pregnancy as spontaneous abortions, preterm labor (107), small for gestational 








3 AIMS OF THE THESIS 
 
The overall aim of this thesis was to identify risk factors for poor neonatal outcome and 





Study I:  To describe neonatal outcomes in pregnancies with reduced fetal movements 
and to identify risk factors for poor neonatal outcome in this cohort.  
 
 
Study II: To investigate if a multidisciplinary audit could identify avoidable factors and 
delays that contribute to stillbirths. 
 
 
Study III:  To evaluate the potential existence of a microbiome in the placenta and the 
amniotic cavity in term pregnancies. 
 
 
Study IV: To investigate if Doppler indices and angiogenic factors can be used as predictors 









4 MATERIAL AND METHODS 
 
A more detailed description of the methods is provided in the articles and manuscripts at the 
end of the thesis. All statistical analyses were performed in SPSS software version 25 (IBM 
Corp.). A brief overview of the papers and study design is provided in table 1.  
 
Table 1. Brief overview of study designs 











Prospective cohort study 
Setting 
 











care at Soder 















section or vaginal 
deliveries during 
March to October 
2017 
Women with singleton 
pregnancies, of more 
than 34 weeks of 
gestation who attended 
health care for RFM 
between Maj 2016 and 
December 2017 
Participants 3243 79 76 128 








4.1 STUDY I 
Study I is a retrospective cohort study on all pregnancies with reduced fetal movements at 
Soder Hospital between January 2016 and December 2017. 
Inclusion criteria were singleton pregnancy, ≥ 22 weeks of gestation, who attended 
obstetrical care at Soder Hospital due to reduced fetal movements.  
The primary outcome was:  
A composite neonatal outcome where one or more of the following criteria were met: arterial 
pH in umbilical cord ≤7.1, 5 minutes Apgar ≤7, transfer to neonatal ward and stillbirth.  
To compare the group with and without RFM, Chi-square and Mann-Whitney U test were 
used. A multivariable model was built with the risk factors that were significant in the 
univariable analysis. 
The demographics of the women and new-born included in the study were presented as 
frequencies with percentages and medians with min-max values.  
The Chi-square automatic interaction detection analysis was used to identify the risk factors 
associated with composite neonatal outcome in the group with RFM.  
4.2 STUDY II 
Study II is a retrospective cohort study were all stillbirths in Stockholm 2017 were included. 
An audit team of three obstetricians, one midwife and one neonatologist was assembled. All 
members of the team assessed all the stillbirth cases independently and then each case was 
discussed during the meetings. 
Inclusion criteria: all stillbirth in Stockholm. With stillbirth defined as intrauterine fetal death 
at ≥ 22 weeks of gestation. All medical data regarding the antenatal care, the women health, 
pregnancy, and delivery were collected from the medical journals. 
The primary outcomes of the study were: 
 Preventable/non-preventable deaths 
 The level of delay if there was any 
The secondary outcomes were: 
 Causes of death 




4.3 STUDY III 
Study III is a cross-sectional study and was conducted at Soder Hospital between March 2017 
and October 2017.  
Inclusion criteria:  
Two groups of term births were included: 50 pre-labor elective cesarean sections and 26 
vaginal deliveries. The women were Swedish or English speaking and above 18 years of age. 
All known fetal pathologies were excluded. 
Primary outcome: placental microbiome 
Secondary outcome: bacterial load in the amniotic fluid, vernix. 
The general approach of the study was to compare the bacterial profiles of 50 term pre-labor 
cesarean deliveries and 26 term vaginal deliveries. For all 76 deliveries, the placenta 
(maternal side, middle, and fetal side sections), amniotic fluid, and vernix were collected. 
Saliva, a vaginal swab, and a rectal swab were also collected.  
The bacterial load in all placental, amniotic fluid, and vernix samples, as well as 
technical/negative controls, were characterized through 16S rRNA gene qPCR. Targeted 
taxa-specific qPCR and 16S rRNA gene sequencing were additionally performed on maternal 
side placental samples. Bacterial culture was performed on all placental samples. The 
bacterial profiles of saliva, the vagina, and the rectum were characterized through shotgun 
metagenomic sequencing. Lastly, bacterial growth inhibition experiments were performed 
using Escherichia coli and placental samples. 
4.4 STUDY IV 
Study IV is a prospective cohort study conducted at Soder Hospital between May 2016 and 
December 2017.  
Inclusion criteria: pregnant women seeking care due to RFM, Swedish or English speaking, 
singleton pregnancies, ≥ 34 weeks of gestation, no knowledge of fetal pathology.  
The primary outcome was a composite neonatal outcome composed of one or more of the 
following criteria: arterial pH in umbilical cord ≤7.1, 5 minutes Apgar ≤7, transfer to neonatal 
ward, stillbirth and/or small for gestational age (SGA). 
The women included in the study were offered after the standard care checkup an extra 
ultrasound examination of pregnancy in which Doppler parameters such as arteria uterine 
pulsatility index (PI), middle cerebral artery PI and umbilical cord artery PI were assessed. 
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The cerebroplacental ratio (CPR) was than calculated as a fraction between middle cerebral 
artery PI and umbilical artery PI. 
Peripheral blood of the women included in the study was collected and centrifugated within 30 
minutes from collection and then stored at −80°C until use. Angiopoietin1(LXSAHM-01), 
Angiopoietin-2, PIGF and VEGFR1/Flt1 (LXSAHM-03) and VEGF were analyzed. 
Plasma levels were measured using the multiplex human immunoassay kit from R&D 
Systems/ Biotechne. The procedure of Luminex analysis was follow according to 
manufacturer’s instruction. 
Four predictive models were then constructed: one based on standard care, standard care and 





















5.1 STUDY I 
The flowchart of the pregnancies included in the study is presented in the figure 5.
 
From January 2016 to December 2017 there were 3243 women who seek obstetrical care due 
to RFM at Soder Hospital. During the same period, there were 11944 singleton deliveries 
without RFM. Figure 6 shows the number of patients seeking care for RFM and the number 
of deliveries each month during the study period. 
When comparing the two groups with and without RFM the women with RFM were younger 
(31 vs 33 years, p<0.01), more likely to smoke 3 months before the pregnancy (13.4% vs. 
9.2, p<0.01), more likely to be nulliparous (57.1% vs. 44.6%, p<0.01) and have a history of 
psychiatric disorders (18.2% vs. 12.6%, p<0.01). 
Regarding the composite neonatal outcome there were no statically significant differences 
between the two groups. Still when analyzing each parameter constructing the neonatal 
composite outcome there was an increased risk for the newborns from pregnancies with RFM 
of having a low Apgar (RR 1.56, 95% CI 1.25-1.96), low arterial pH at birth (RR 1.34, 95% 
CI 1.12-1.61) and stillbirth (RR 5.53, 95% CI 2.81-10.85). 






When comparing the group with recurrent RFM and the one with single episodes there were 
no statistically significant differences in the parameters that constitute the composite neonatal 
outcome, however the women with recurrent RFM were more likely to be nulliparous (62.6% 
vs. 55.9%, p=0.04) and have IVF pregnancies (9.1% vs. 6.6%, p=0.04). 
There was an increased percentage of inductions of labor in the RFM group compared with 
the controls (23.5% vs. 16.5%, p<0.01). 
The results from the Chi-square automatic interaction detection analysis showed that the 
highest risk for having the composite neonatal outcome was in the group with SGA fetus 
(18.4%), followed by the group with IVF (12.8%). 
 
5.2 STUDY II 
The rate of stillbirth in Stockholm has varied between 2.8-4.0/1000 livebirths for the past 
decade. When comparing the stillbirths group (n=79) with the liveborn group (n=28584) In 
Stockholm 2017 there are no statistical significant differences in age, pregnancy 
complications, smoking, IVF. In the group of stillbirths, the women of African origin (19.2% 
vs. 6.3%), the women with at least one previous miscarriage (33.3% vs 23.9%) and the SGA 
babies (40.5% vs. 3.9%) are overrepresented.  
One of the primary outcomes was preventability of the stillbirth and 30.4 % of 79 stillbirths 
were assessed as possibly preventable (6/35 early stillbirths and 18/44 in the late stillbirth 
 




group). There was a statistically significant difference between the group of Swedish 
speaking and non-Swedish speaking women regarding the preventability of stillbirth (24% vs 
56%). 
In 17% of the cases a patient delay was registered and in 15 % of the cases a delay due to the 
health care system. 28% of the cases were assessed as substandard antenatal care and 18% as 
substandard postnatal care. 
The most frequent cause of death was IUGR/placenta insufficiency (20.8%) and 60.8% of the 
cases had more than one diagnosis that was associated with the stillbirth. 
 
5.3 STUDY III 
There were no statistical significant differences in the demographics of the women (n=76) 
and infants (n=77) included in the study when looking at the group of pre-labor cesarean 
section deliveries vs vaginal deliveries except regarding parity. 
When analyzing the 16S rRNA gene by quantitative amplification and sequencing, the 
microbial content of the placenta was not higher than the background signals. A median of 
57% of each sample were categorized as laboratory contaminants (figure 7). 
 
 





The maternal side of the placenta had the highest gene counts in both groups and was 
therefore chosen to validate the findings above by targeted qPCR for 10 specific bacterial 
taxa that could be expected to be found in the placenta based on previous published work. 
There were no statistically significant differences between the groups. 
In the culture experiments, there were significantly more bacterial cultures observed in 
placental tissues from vaginal deliveries compared to cesarean section deliveries (table 2). 
Table 2. Bacterial growth of placenta tissues according to delivery mode 
Data expressed as absolute and relative values for total plate count n (%). CFU: Colony-forming Units. p-value for 
differences between delivery groups at the level of CFU range. The significance level was set at p<0.05. Fisher’s Exact test 
was used for comparison. 
The key findings of the study were: 
1) Bacterial signals in placental tissues, amniotic fluid, and the vernix did not exceed that of 
negative extraction controls. 
2) The 16S rRNA gene profiles of the maternal side of the placenta in women who had not 
taken antibiotics in pregnancy were largely dominated by contaminants (87% of amplicon 
sequence variants were deemed to be contaminants; most of the remaining sequence data 
were from the genera Massilia and Escherichia). 
3) Bacterial culture yielded skin and vaginal bacteria, and was influenced by mode of 
delivery. Specifically, when there was bacterial growth from a cesarean-delivered placenta, 
the recovered bacteria (Propionibacterium, Streptococcus and Staphylococcus) were 
consistent with skin contamination during the surgery (figure 8). 
4) The bacterial growth inhibition assay demonstrated that placental tissues had a modest 
inhibitory effect on bacterial growth, particularly if the tissue had a high bacterial load as 
determined by qPCR. 
 Delivery mode  
CFU 
range 

























0 28 (54.9) 29 (58.0) 30 (58.8) 8 (30.8) 9 (34.6) 4 (15.4) <0.001 
1 – 5 17 (33.4) 13 (26.0) 10 (19.6) 7 (26.9) 5 (19.2) 5 (19.2) 0.787 
6 – 30 4 (7.8) 3 (6.0) 8 (15.7) 3 (11.5) 6 (23.1) 10 (38.5) 0.996 







Fig.8 Bacteria grown from placentas are predominantly typical skin and vaginal taxa  
 
(a) GC agar plates showing the bacterial growth from placental tissues after 48 hours. The placenta cultures are 
represented in ranges according to the number of colony-forming units (CFUs). “P” stands for participant. (b) 
Histogram showing frequency (%) distributions of CFUs according to the placental sample type and the 
delivery mode. Chi-squared tests (Fisher’s exact tests) were performed with significance level at p = 0.05. The 
comparison was between vaginal delivery (white bars) and cesarean delivery (black bars) in each CFU-range 
group. (c) Treemaps showing the relative proportion of taxa that grew in culture by location in the tissue and 
mode of delivery. 
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5.4 STUDY IV 
Between January 2016 and December 2017, 3243 women attended health care for RFM at 
Soder Hospital. 128 women participated in the study and an extra Doppler examination was 
performed. The women included in the study were more likely to be multipara (51.6% vs 
42,3%, p<0.04), to attend health care for RFM multiple times (32% vs 16.6%, p <0.01) 
compared with the controls (RFM with standard care). It was more common for the women 
in the study group to be induced (36.9% vs 23.1%, p<0.01), but there were no statistically 
significant differences in the delivery mode.  There were no stillbirths in the study group and 
there were no statistically significant differences in the composite neonatal outcome. 
Within the study group there was a higher rate of obstetrical interventions such as follow-ups, 
hospitalization, or induction of labor when the extra Doppler was performed compared with 
standard care (28% vs 5.4%, p<0.01).  There were no differences in the MoM CPR, MoM 
UtA and MoM MCA between the group with and without composite neonatal outcome. 
In 62 women of the study group the angiogenic factors (Angiopoietin-1, PlGF and VEGF) 
and the antiangiogenic factors /Angiopoietin-2 and sFlt1) were analyzed. The median value 
of these factors did not differ between women with and without composite neonatal outcome. 
The predictive model constructed with the angiogenic, antiangiogenic factors and parity had a 
















6.1 STUDY I 
The main results of the study are presented in figure 9. 8.5% of the cases had a composite 
neonatal outcome in the group with RFM. The group of SGA babies and IVF pregnancies 
had the highest risk of poor neonatal outcome with 18.4% and 12.8% respectively.  
The rate of presentation for RFM was 22% during the study period which is higher than the 
previous reported rates in other studies 8-17%  (23, 110, 111), proving once again that RFM 
is a very common symptom during pregnancy.  
Recurrent visits were 17.3% of the presentations with RFM which is lower compared to other 
studies that have reported up to 46% (112). In accordance with a previous study (112) there 
were no statistical significant differences in the neonatal outcome between women who 
presented for RFM once or multiple times. However other studies have reported an increased 
percentage of SGA babies in the group with recurrent RFM (111). Significant RFMs are 
likely to be late in the sequence of events that precedes fetal death: e.g. most severe IUGR 
babies move normally on scan. A pre-terminal event, usually just before CTG abnormalities, 
Fig.9 Tree classification of the risk factors for composite neonatal outcome in the RFM group. 
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will not happen multiple times. So, either recurrent RFMs is extremely serious or it is almost 
nothing.  
When looking at the IVF pregnancies within the RFM group, there were statistically 
significant more nulliparous (76.4% vs 55.7%, p<0.01) and they sought care for RFM 
multiple times more frequent than the non-IVF group (22.3% vs 16.9%, p=0.04). Even more 
interesting is the neonatal outcome where the IVF group has a higher rate of SGA babies, 
neonatal ward and of poor neonatal outcome (table 3). 
    
Table 3. Neonatal outcomes for the group with reduced fetal movements and IVF (n=229) 
and the group with RFM and no IVF (n=3007).   
Poor Neonatal Outcome 
Score 
Pregnancies with IVF 
Pregnancies with no 
IVF 
p-value* 
  N = 227 n = 3007   
 
   
Apgar** ≤7 at 5 min (%) 8 (3.5) 94 (3.1) 0.69 
Arterial pH**≤ 7.10 (%) 13 (6.6) 137 (5.8) 0.63 
Neonatal ward transfer (%) 15 (6.6) 77 (2.6) <0.01 
Stillbirth (%) 2 (0.9) 15 (0.5) 0.34 
SGA (%) 16 (7.0) 108 (3.6) 0.02 
Composite outcome (%) 30 (13.1) 241 (8.0)) 0.01 
* significant if <0.05    
**Not available on all neonates  
    
Identifying the pregnancies with SGA in the RFM group could help us find the pregnancies 
with the highest risk of poor neonatal outcome. Previous studies have shown that a third 
trimester ultrasound in low-risk pregnancies may detect more SGA even if it does not affect 
the neonatal outcome (48, 49). However, a third trimester ultrasound for estimating the fetal 
growth in RFM population can be beneficial. 
 
6.2 STUDY II 
The main results of the multidisciplinary audit showed that there are 30% of the stillbirths in 
Stockholm that were assessed as possibly/probably preventable. The non-Swedish speaking 
women were overrepresented in this group. However, there were no statistically significant 
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differences regarding the preventability of stillbirth when just looking at the country of birth 
of the mother. Also, when assessing the level of delay in non-Swedish speaking women there 
was more often a patient related delay (37% vs 11%). There were even differences in the 
delays at the healthcare level, but not as high (19% vs 14%). These inequalities in the care 
were noticed even in other settings, like for example Italy where the preventable deaths 
occurred more frequently in non-Italian women (113). 
This can be due to difficulties in understanding the information given at the ANC, difficulties 
in understanding how the healthcare system works and how to navigate a completely new 
healthcare system, especially when every contact with healthcare personnel is based on 
telephone contact. Previously published data from Sweden showed that women who have 
lived less than 5 years in Sweden have  an increased risk of stillbirth (114). One could 
speculate that by providing adequate translation, an understanding of the healthcare system 
and culture doulas the quality of care can be improved for this group of patients. 
The interventions that could have prevented the stillbirths were for example: earlier induction 
of labor, cesarean delivery, more frequent ultrasound, or extra clinical follow-ups. 
There are over 35 classification systems in use internationally. In this study, we used the 
Stockholm stillbirth classification system (33). Compared with other systems there was a 
smaller percentage of cases that were classified as being of unknown cause (7.6% in our 
study compared with approximately 20% or 30% in other studies) (31, 115). 
When looking at the protocol of the investigation for stillbirth there were no statistically 
significant difference between Swedish speaking and non-Swedish speaking women 
regarding incomplete investigation (6% vs 21%, p=0.28), placental examination (100% for 
both groups), karyotype (87% vs 100%, p=0.19) and autopsy (70% vs 50%, p=0.27). This 
confirms what has been shown in previous studies that all parents are extremely interested to 
find out the causes of death and in planning how to prevent it from happening again in the 
next pregnancy (116).  
This kind of information on variables such as Swedish speaking or not is unfortunately 
difficult to assess when analyzing large register data sets.  This is one among many others 





6.3 STUDY III 
The main results of the study were that bacterial DNA from the placenta did not exceed the 
levels of the negative controls and that cultures from placental tissue yielded skin and vaginal 
bacteria depending on the delivery mode. Moreover, the placental tissue had an inhibitory 
effect on the bacterial growth. These findings confirmed that there is not a placental 
microbiome in normal healthy pregnancies. 
There are contradictory results published regarding the existence of a placental microbiome 
(100, 102). The main difficulties in interpreting/analyzing the results of this type of studies 
are that the modern DNA-based methods are extremely sensitive and that there are traces of 
DNA everywhere: water, air, lab reagents. Moreover, there are differences in the population 
included in the studies (preterm and complicated pregnancies), the duration from delivery to 
sampling the placenta, that can partially explain the differences in results between studies. 
The intrauterine environment is equipped with anti-inflammatory and anti-microbial 
characteristics at different levels:  placenta, amniotic fluid, vernix, and fetal membranes. The 
physiology of the intrauterine environment and the fact that it is possible to breed germ-free 
animals seem to sustain our conclusions. 
The conclusion of the study was that the evidence of bacterial presence in the human placenta 
at term was insufficient to conclude the existence of a placental microbiome. Although 
sporadic bacteria were found in the placenta of some subjects, these bacteria do not represent 
a placenta microbiome per se. 
 
6.4 STUDY IV 
Additional Doppler examination increased the rate of obstetrical interventions in the RFM 
group since the obstetricians in charge of the case were not blinded to the results and had to 
intervene according to the local guidelines.  
Previous studies have shown that in midwifery-led practices in high-income countries a 
combination of low intervention rates, low cost and best outcomes has been noted (117). 
In the group with additional Doppler there were no statistically differences in the CPR 
MoM between the group with and without composite neonatal outcome and no stillbirths. 
Several research groups (Prior et al, Khalil et al., Dall'Asta et al., Kumar et al.), have recently 
addressed the issue of the identification of subclinical impairment of the placental function in 
apparently normally grown neonates by evaluating the CPR. These studies concluded that the 
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identification of the normally grown fetuses at risk for adverse events antepartum/intrapartum 
still represents an unresolved issue. These conditions are likely to account for the majority of 
the so far unexplained causes of stillbirth.  
Research on angiogenic and antiangiogenic factors have shown that an imbalance between 
the angiogenic and antiangiogenic factors has been associated with placental insufficiency 
and poor neonatal outcome. In our study there were no statistical differences in the median 
values of the factors analyzed between the groups with and without composite neonatal 
outcomes.  
When constructing a prediction model with angiogenic, antiangiogenic factors and parity the 
AUC of ROC was 0.89 which suggests that these factors may have a place in identifying the 
risk pregnancies for composite neonatal outcome within RFM group. The results should be 
interpreted cautiously since the numbers in the study are quite small and there is a risk of 

















7. METHOLOGICAL CONSIDERATIONS 
 
7.1 INTERNAL VALIDITY-SYSTEMATIC ERROR 
Internal validity refers to how well the studies were conducted and how confident the 
researcher can be with the findings in the study. 
7.1.1 Selection bias 
Selection bias is one of the systematic errors that can affect the internal validity of the studies. 
It refers to an error in selecting the participants in the study that leads to differences in the 
relationship between exposure and outcome between those included in the study and the non-
participants (118). 
In study I all women with RFM at Soder Hospital were included over a two years’ period. 
There were less than 10% of the visits for RFM that were delivered in other counties or 
countries and delivery data with the outcome was not available. The composite neonatal 
outcome was created due to the clinical significance and due to low numbers of cases in each 
of the categories. 
In study II which is a retrospective cohort study all women with stillbirth in Stockholm 
during 2017 were included. All cases were including in the analysis.  
There was no loss to follow up in studies III and IV. In study III all eligible women for 
participating in the study were invited. There were only two patients of 78 invited who 
refused to participate due to fear of discomfort when taking the samples. 
The inclusion rate in study IV was very low and that is mainly due to patients not being 
invited to participate. We estimate that around 10% or less of the patients were asked to 
participate. This was due to high workload of the medical personnel and the possibility of 
having extra ultrasound examinations just once a day during office hours. In this study, only 
Swedish and English-speaking women were included in the study due to the lack of 
possibilities of translating the informative material. This can contribute to selection bias as 






7.1.2 Information bias 
Another type of systematic error is the information bias which occurs during data 
collection. The most common type of information bias is misclassification where for 
example exposed participants are classified as non-exposed or participants with the 
outcome are classified as not having the outcome (118). 
In a retrospective cohort studies, such as study I and II, there are some limitations that are 
specific for this type of research. Whenever conducting register-based studies the 
researcher relies entirely on the data quality existing in the register. For all studies, the 
statistical analysis and regressions were based on complete cases. There were no multiple 
imputations for the missing values. 
Study II was a retrospective study, but also a multidisciplinary audit. The information in all 
the medical journal was assessed and interpreted by each member of the audit team 
individually and after that discussed at the meetings. There was consensus on the evaluation 
of the cases at all, except two cases. 
Studies III and IV were prospective studies were researcher went through all the medical 
journals of all women included in the studies. This can minimize the risk of 
misclassification, missing values, or information bias. One of the problems inherent with 
prospective studies is the lost to follow up, which was not topical for our two studies. 
 
7.1.3 Confounding 
A confounder is a variable that influences both the exposure and the outcome. When 
planning a study, it is important to choose which confounders we adjust for, otherwise they 
can introduce bias. Even so, there is still a risk of residual confounding which can be 
known and discussed or unknown.  In the latter case, there is no way of knowing their 
impact on the exposure or on the outcome. 
The decision on the variable included in each study was made after discussion between 
clinicians and depending on variable availability in medical journals. 
In study I in the multivariable regression analyzes we controlled for possible confounders 
and interactions. In study I the final model was constructed by initially analyzing the known 
risk factors for having the composite outcome: high BMI, advanced maternal age, smoking, 
parity, pregnancy complications, IVF. After analyzing the association for each individual 
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factor, a multivariable model was constructed with only the statistically significant 
variables from the univariable analysis. When analyzing the interactions between the 
significant variables an interaction between IVF and parity was noted and was accounted 
for in the new multivariable model. IVF is interesting in study I since its association with 
stillbirth is generally thought to be small and we have in the regression model adjusted for 
maternal age. We have not found described in the literature a clear association between IVF 
with RFM and stillbirth. There is a known association between IVF and low birth weight, 
though the etiology is still unclear. In our dataset, the finding with increased risk was not 
related to high age, parity, or SGA. It may therefore be a yet unknown confounding variable. 
A direct acyclic graph (DAG) can be used to display the relationship between different 
variables and /or the outcome and to identify possible causal pathways. The DAG 
methodology can be used to help select the variables included in the study and to construct 
a model where bias is reduced. A DAG was constructed for study I using the free online toll 
DAGitty (119) (figure 10). 
7.2 POWER CALCULATION 
In study I all patients with RFM at Soder Hospital during a two years’ period were included. 
In study II all stillbirths in Stockholm 2017 were included. In study III the aim of the study 
was to describe the placental microbiome in full-term pregnancies and the number of cases 
Fig.10 A visualization of possible confounders on Study I 
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included was based both on previous published articles and on a pragmatic calculation on 
what is feasible. When study IV was designed, and the inclusion began there were no studies 
describing the predictors which we wanted to investigate in the group of patients with RFM. 
Because of that it was not possible to assume about expected differences between the groups. 
 
7.3 RANDOM ERRORS 
This type of errors is unpredictable and cannot be replicated if the experiments are repeated. 
To express the precision of the results of the experiment p-value and CI are used. With a 
small sample size, the CI will be wider and there is a risk of not being able to prove the real 
differences between the groups. 
Study I has a large sample size and the random errors are not a problem. Study II has a small 
population of stillbirths that we are comparing with all deliveries in Stockholm and all 
stillbirths in Sweden (which are large samples). But when analyzing only the group of 
stillbirths in Stockholm, the results should be interpreted cautiously.   
Random errors can be avoided by increasing the sample size. Study IV has a small number of 
participants and the results would be more accurate if the sample size was increased. 
However, at the time of the study it was not possible to increase the number of ultrasound 
examinations and this is a pilot study meant to generate the hypothesis for future studies. 
 
7.4. CROSS-VALIDATION  
Cross-validation is a technique used to prevent the problem of overfitting a model. To 
tackle this problem the dataset is usual split in test subsets so we can test that the prediction 
model will perform well on new data. 
In study IV we investigated possible ultrasound and angiogenic factors predictors of the 
neonatal outcome. In this study, there are no problems with confounders since we are not 
looking at a causality relation. There is a possible risk of overfitting the model in this study 
due to the small number of cases/outcomes included in the study. Of the same reason, it 
was not possible to do a cross-validation of the dataset. This study was designed as a pilot 




7.5 EXTERNAL VALIDITY AND GENERALIZABILITY 
External validity refers to how applicable the results of the studies are in different 
populations; how generalizable the findings are. 
Study I includes pregnancies seeking care for RFM in an urban setting, at a secondary 
hospital with almost 8000 deliveries a year. The demographic of this population can be 
slightly different from the rest of Sweden, but the result can be applied in similar settings in 
Sweden or Western Europe. 
Study II is a small study were all stillbirths in Stockholm for one year were included. It is 
very difficult to include large numbers of patients due to the rarity of the outcome. In order to 
get more information about the generalizability of the results, a comparison with the whole 
group of stillbirths in Sweden and of all the livebirths in Stockholm during the same period 
was made. 
Study III included a small number of full-term normal pregnancies from similar setting as 
Study I. In this study the presence of microbiome in the placenta was investigated. The study 
describes the intrauterine environment regarding the microbiome and the results can be 
extrapolated to full-term uncomplicated pregnancies in general. 
Study IV is a prospective pilot study of women who seek care for RFM aiming to investigate 
if ultrasound and angiogenic markers can be helpful in predicting the fetal wellbeing in these 
pregnancies.  The results can be applied in similar obstetric settings and for comparable 
populations. 
In study III and IV only English and Swedish speaking women who could understand the oral 
and written consent and information were included in the studies. This can of course affect 








8. FUTURE RESEARCH 
Even if one could consider that the incidence of stillbirth is low in Sweden, every single lost 
child is a personal tragedy. Despite increased awareness on fetal movements in the media and 
among health care providers, the incidence has remained almost constant during the last three 
decades. We still need to find new methods of identifying the risk pregnancies in the group of 
RFM. 
Thoughts on future projects: 
1. To investigate the neonatal and maternal outcome of pregnancies where the labor is 
induced due to reduced fetal movements. 
2. To investigate the molecular mechanism of stillbirths, including the microbiome of 
women and new-borns in stillbirths. 
3. A prospective study to investigate the pregnancy outcome of non-Swedish speaking 













9. ETHICAL CONSIDERATIONS 
 
9.1 General considerations 
One of the aims of the research was to assess the efficacy of our present methods of 
investigating this group of women (with RFM) and to study if there are other diagnostic 
methods than the ones in use. Another aim of the study is to try and improve the standard, 
outcome, and knowledge for the patients with decreased fetal movements. 
Ethical approval has been obtained for all 4 studies from the Regional Board of Ethics in 
Stockholm. Study III-IV were prospective studies. If the participants met the inclusion 
criteria and there were no contraindications or exclusion criteria, the women gave their 
written informed consent to participate in the studies. All participants in these studies 
received both oral and written information about the studies. Any of the participants could at 
any time decide to withdraw from the studies without affecting the treatment of women or 
infant.  
Study I and II are retrospective register-based studies were all study participants are given a 
serial number and during the analysis phase the individuals cannot be identified. In all the 
studies, all data regarding the patients was recorded and stored appropriately and according 
with established legislation and guidelines. Files were password-protected and was accessible 
only to the researchers involved in the studies.  
In study IV an additional ultrasound was done and blood, urine and saliva were sampled from 
the study participants. We assessed that no harm was caused to the participants beside the 
discomfort of the blood sample. In study III all the samples were collected during the 
cesareans section or during the vaginal delivery at the time when performing the standard 
procedures 
All biological material was anonymized and impossible to trace to the patient’s identity when 
handling and analyzing the samples in the laboratory. The materials were stored in 
accordance with the laws for biobanks in Sweden.  Sample donors could at any time 





9.2 The goodness and no harm principles 
When designing and performing the studies we always tried to apply the goodness principle 
and principle of no harm. We assessed that the gain for the study population is greater than 
the discomfort of collecting the samples. No direct benefit can be predicted for the women 
included in the study. Earnings are more long term in nature. We aimed to gain not only more 
information about this heterogenous group but also hopefully even identify new methods of 
predicting the risk population for stillbirths.  




















10. SVENSK POPULÄRVETENSKAPLIG 
SAMMANFATTNING 
 
Intrauterin fosterdöd (IUFD) är en av de mest allvarliga graviditetskomplikationerna. Varje år 
dör drygt 400 foster intrauterint vid en graviditetslängd ≥ 22 veckor. Globalt dör ca 2,65 
miljoner barn intrauterint (vid graviditetslängd över 28 veckor). I Sverige är incidensen av 
intrauterint döda foster/1000 födda barn 3,8-4,4. Trots ökad uppmärksamhet i media samt 
ökade insatser inom mödrahälsovården har incidensen varit i stort sett oförändrad i Sverige de 
senaste 25 åren.  
Bakomliggande orsakerna till IUFD kan vara infektion, moderkaks- och navelsträngs- 
komplikationer, missbildningar och kromosomavvikelser, dålig tillväxt av fostret samt 
sjukdomar hos modern. Men vissa gånger är IUFD dock helt oförklarligt.  
Fosterrörelser är en viktig parameter för utvärdering av fostrets välmående. Frekvensen och 
kvinnans känsla av fosterrörelser varierar under graviditeten med en successiv ökning från 
graviditetsvecka 16 till 36, för att sedan minska något den senaste månaden innan 
förlossningen. Fosterrörelser varierar beroende på fostervattenmängd, fostrets bjudning, 
mammans medicinering och hälsotillstånd. Det finns inget facit för hur många fosterrörelser 
en blivande mamma faktiskt ska känna under graviditeten, vad som är normalt och vad som 
är onormalt. Tidigare studier visar dock att minskade fosterrörelser har ett samband med 
graviditetskomplikationer så som IUFD.  
Minskade fosterrörelser är idag ett hett debatterat ämne. Sedan 2011 har många artiklar 
publicerats och mycket information presenterats i svenska dagstidningar samt sociala media. 
På Södersjukhuset i Stockholm söker ungefär 2500 kvinnor per år då de upplever att fostret 
rör sig mindre intrauterint. Svårigheten i den obstetriska vardagen är att kliniskt handlägga 
denna stora patientgrupp. Erfarenheten säger att de flesta av dessa graviditeter är normala, 
och målet är en så liten interventionsgrad som möjligt. Samtidigt döljer sig riskgraviditeterna 
bland dessa fall. En Cochran-översikt från 2012 som studerade handläggningen av kvinnor 
som söker för minskade fosterrörelser konstaterade att det inte fanns tillräcklig information 
från de randomiserade studier som är gjorda om den bästa handläggningen av dessa 
graviditeter.  
I denna avhandling ingår fyra studier. I första delstudien var målet att identifiera riskfaktorer 
associerade med dåligt neonatalt utfall i gruppen av gravida som sökte vård för minskade 
fosterrörelser på Södersjukhuset under 2016–2017. Studien visade att i gruppen med 
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minskade fosterrörelser, hade barn som är små för gestationsåldern den högsta risken för 
dåligt neonatalt utfall (ca 18,4%), följd av IVF graviditeter (12,4%). 
Den andra delstudien var en multidisciplinär regional audit angående alla intrauterina 
fosterdödsfall i Stockholm 2017. Audit gruppen gjorde en bedömning av alla fall. Totalt 30 % 
av IUFD klassades som möjliga att förhindra. I 15% av fallen bedömdes att det var 
förseningar i handläggningen som var vårdrelaterad. En eventuellt förebyggbar IUFD var 
vanligare bland icke-svenskspråkiga kvinnor (p=0.03). 
I 20% av IUFD finns histologiska tecken på infektion vid undersökning av placenta, utan att 
vi alltid kan bevisa en infektion med odlingar. Tanken med den tredje studien var att 
kartlägga om det finns ett mikrobiom intrauterint under en normal fullgången graviditet. 50 
kvinnor som genomgick planerat kejsarsnitt innan värkarbetets start och 26 kvinnor som 
födde vaginalt inkluderades i studien. Prover från placentan, fostervattnet, fosterfettet 
analyserades. Vi hittade inga tecken på ett mikrobiom i normala graviditeter.  
I den fjärde delstudien studerades faktorer som kunde predicera neonatalt utfall för 
graviditeter där kvinnorna upplevde minskade fosterrörelser. Kvinnor som sökte vård för 
detta på Södersjukhuset under 2016–2017 erbjöds att delta i studien och att genomgå ett extra 
ultraljud av fostret där man undersökte flödet i navelsträngen och flödet i en artär i barnets 
huvud.  I samband med undersökningen togs också ett blodprov på kvinnan för att analysera 
syrebristrelaterade faktorer i blodet. Att göra en extra ultraljudundersökning ledde till ett 
signifikant högre antal obstetriska interventioner såsom igångsättning av förlossningen, 
inläggning på antenatal-avdelning eller extra kontroller. En bra prediktiv modell har erhållits 
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